Zylox-Tonbridge

Zylox-Tonbridge Medical Technology Co., Ltd. (Stock Code: 2190.HK) Zylox-Tonbridge is a publicly listed company on the Hong Kong Stock Exchange (Stock Code: 2190.HK), recognized as a reliable partner in the peripheral and neurovascular interventional medical device market. Guided by our mission of "Innovation for Quality Life," we are dedicated to advancing healthcare through cutting-edge technologies and comprehensive medical solutions. Since our establishment in 2012, we have built a robust portfolio of over 50 products, addressing the growing demands of neurovascular and peripheral vascular interventions. With strong research and development capabilities, advanced manufacturing systems, and a track record of successful product commercialization, Zylox-Tonbridge has established itself as the market leader in China and is steadily expanding its presence in international markets. By partnering with healthcare professionals and distributors worldwide, we are committed to improving patient outcomes and advancing standards in medical care. Together, we are building a healthier future driven by innovation and quality.